Frontiers in Cardiovascular Medicine

FEBRUARY 27, 2025

BackgroundInstant atrial fibrillation termination (AFT) during radiofrequency ablation has been suggested as a predictor of prognosis in persistent atrial fibrillation (AF). Baseline characteristics, procedural details, and clinical outcomes were compared between the groups.ResultsA total of 189 patients [65.0

Atrial Fibrillation 52

Atrial Fibrillation Ablation Arrhythmia Outcomes 52

Medical Xpress - Cardiology

MAY 18, 2024

Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S.

Atrial Fibrillation 85

Atrial Fibrillation Best Practices Outcomes Heart Rhythm 85

Open Heart

JANUARY 21, 2025

Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both conditions. Whether the risks of outcomes differ according to temporal order of AF and AMI is unclear.

Myocardial Infarction 52

Myocardial Infarction Atrial Fibrillation Diet Cancer 52

Heart BMJ

JANUARY 29, 2025

Background The SCN5A gene polymorphism histidine-558-to-arginine (H558R) has been associated with atrial fibrillation (AF) and may affect the therapeutic effects of flecainide. Secondary analyses evaluated the long-term outcomes and compared the prevalence of H558R in the AF cohort to a general population sample (n=3401).

Atrial Fibrillation 52

Atrial Fibrillation Outcomes 52

Cardiovascular Diabetology

APRIL 4, 2024

This study investigates the relationship between triglyceride-glucose (TyG) index trajectories and the results of ablation in patients with stage 3D atrial fibrillation (AF).

Atrial Fibrillation 105

Atrial Fibrillation Ablation Outcomes Research 105

DAIC

APRIL 18, 2024

Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrial fibrillation ablation, Musat et al. recommend shortening the blanking period from three months to one. also emphasize the importance of continuous monitoring.

Atrial Fibrillation 111

Atrial Fibrillation Ablation Heart Rhythm Article 111

The New England Journal of Medicine

APRIL 2, 2025

After atrial fibrillation ablation, left atrial appendage closure was associated with a lower risk of bleeding than oral anticoagulation and was noninferior to oral anticoagulation with respect to clinical outcomes at 36 months.

Atrial Fibrillation 74

Atrial Fibrillation Ablation Outcomes 74

Medical Xpress - Cardiology

DECEMBER 18, 2023

Postoperative atrial fibrillation (POAF) is associated with an increased rate of neurologic events and worse long-term survival, according to a study published online Sept. 11 in the Journal of Thoracic and Cardiovascular Surgery.

Atrial Fibrillation 83

Atrial Fibrillation Cardiovascular Surgery Outcomes 83

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. "The Circulation.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

HeartRhythm

APRIL 8, 2024

There is insufficient data assessing the regional differences in catheter ablation outcomes for atrial fibrillation (AF) in the United States.

Atrial Fibrillation 75

Atrial Fibrillation Ablation Outcomes Inpatient 75

HeartRhythm

SEPTEMBER 20, 2024

Data on long-term effects of catheter ablation versus antiarrhythmic drugs (AAD) on health-related quality of life (HRQoL) and atrial fibrillation (AF) burden are limited.

Quality of Life 81

Quality of Life Atrial Fibrillation Ablation Outcomes 81

Medical Xpress - Cardiology

JULY 24, 2024

Using a wearable device, such as a smart watch, to track health data and symptoms, is supposed to help people monitor their health and address symptoms as quickly as possible to spur positive health outcomes.

Atrial Fibrillation 75

Atrial Fibrillation AFIB Outcomes 75

HeartRhythm

MARCH 10, 2025

Ablation index (AI)-guided pulmonary vein isolation (PVI) has enhanced procedural outcomes for atrial fibrillation (AF).1 1 However, patients with persistent AF present higher recurrence rates due to advanced atrial remodeling,2-3 represented by the left atrial low voltage area (LVA), compared to those with paroxysmal AF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2025

This high incidence of cognitive decline in AF patients may result from various mechanisms, including reduced cerebral perfusion, microembolism, decreased cardiac output, and chronic inflammation.MethodsThis review synthesizes current evidence on the relationship between AF and cognitive impairment, examines underlying mechanisms of cognitive decline (..)

Atrial Fibrillation 52

Atrial Fibrillation Arrhythmia Ablation Research 52

American College of Cardiology

APRIL 18, 2025

Patients who undergo catheter ablation for atrial fibrillation (AFib) who also have heart failure with preserved ejection fraction (HFpEF) experienced a greater benefit from ablation in terms of clinical outcome, AFib recurrence and functional status, according to findings from the CABANA trial.

Preserved Ejection Fraction 75

Preserved Ejection Fraction Ablation AFIB Outcomes 75

HeartRhythm

MAY 15, 2024

With the exponential growth of catheter ablation (CA) for atrial fibrillation (AF), there is increasing interest in associated healthcare costs.

Atrial Fibrillation 72

Atrial Fibrillation Ablation Outcomes 72

Journal of Cardiovascular Electrophysiology

APRIL 9, 2025

ABSTRACT Background Sotalol is used for the maintenance of sinus rhythm among patients with atrial fibrillation. To date, use and outcomes by dose are not well-described. However, there is discretion regarding dosing of chronic therapy, and the target oral dose dictates infusion doses for intravenous sotalol loading.

Arrhythmia 40

Arrhythmia Outcomes Atrial Fibrillation Hospital 40

American College of Cardiology

FEBRUARY 12, 2025

Additional rhythm-control strategies are frequently continued after index ablation for atrial fibrillation (AFib), according to a study published Feb. 12 in JACC: Clinical Electrophysiology.

Atrial Fibrillation 55

Atrial Fibrillation Ablation AFIB Electrophysiology 55

Open Heart

MARCH 28, 2025

The primary outcomes of interest were mortality in ventricular and atrial arrhythmias, and later diagnosis of cardiac disease in atrial arrhythmias. The presence of atrial fibrillation (AF) during stress testing was not associated with mortality at all time points: OR 1.53 (95% CI 0.05, 50.19), p=0.81.

Arrhythmia 75

Arrhythmia Coronary Artery Disease Myocardial Infarction Atrial Fibrillation 75

American College of Cardiology

FEBRUARY 19, 2025

Atrial fibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased risk of heart failure (HF) hospitalization and atrial fibrillation (AFib) recurrence.

AFIB 67

AFIB Ablation Atrial Fibrillation Outcomes 67

Science Daily - Heart Disease

APRIL 22, 2024

Atrial fibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. Researchers have recently developed a deep-learning model capable of predicting the transition from a normal cardiac rhythm to atrial fibrillation.

Arrhythmia 125

Arrhythmia Atrial Fibrillation Dementia Heart Failure 125

Journal of the American Heart Association

DECEMBER 1, 2023

BackgroundAn increased risk of recurrent stroke is noted in patients with atrial fibrillation despite direct oral anticoagulant (DOAC) use. 0.45] for rivaroxaban), and a 69% to 83% reduced risk of net composite outcomes (aHR, 0.25 [95% CI, 0.18–0.35] 0.39] for apixaban, 0.23 [95% CI, 0.14–0.37] 0.41] for rivaroxaban).ConclusionsIn

Atrial Fibrillation 75

Atrial Fibrillation Hemorrhage Pharmacology Stroke 75

Frontiers in Cardiovascular Medicine

FEBRUARY 7, 2024

Background Efforts to maintain sinus rhythm in patients with persistent atrial fibrillation (PsAF) remain challenging, with suboptimal long-term outcomes. Methods All patients undergoing convergent PsAF ablation at our centre were retrospectively analysed.

Atrial Fibrillation 81

Atrial Fibrillation Ablation Document Obesity 81

HeartRhythm

MARCH 31, 2025

Native Americans have a disproportionately poor health outcomes, however their outcomes in atrial fibrillation (AF) have yet to be thoroughly explored.

Atrial Fibrillation 40

Atrial Fibrillation Outcomes 40

Cardiovascular Diabetology

MARCH 23, 2025

The triglycerideglucose (TyG) index, an emerging surrogate marker of insulin resistance, has been implicated in adverse cardiovascular outcomes. However, its prognostic value in critically ill patients with a.

Atrial Fibrillation 102

Atrial Fibrillation Outcomes Research 102

CardiacWire

APRIL 5, 2025

Paroxysmal atrial fibrillation is a type of AFib that causes short, intermittent episodes of irregular and rapid heartbeats originating in the atria. Well still have to wait for future studies to see whether PFAs outcomes will match its safety and efficiency benefits. The post PFA or Cryoballoon for Paroxysmal AFib?

AFIB 59

AFIB Ablation Atrial Fibrillation Pulmonary 59

HeartRhythm

MARCH 31, 2025

Clinical pathways by which patients progress through their atrial fibrillation (AF) care journey are not fully understood and may influence the likelihood of receiving guideline-based AF management strategies to optimize outcomes.

Atrial Fibrillation 40

Atrial Fibrillation Patient Care Outcomes 40

Med Page Today

DECEMBER 21, 2023

(MedPage Today) -- For patients undergoing catheter ablation for atrial fibrillation (Afib), there was no signal that a brief course of colchicine reduced atrial arrhythmia recurrence or improved clinical outcomes when taken for 10 days starting.

Arrhythmia 115

Arrhythmia Ablation AFIB Atrial Fibrillation 115

Heart BMJ

OCTOBER 10, 2024

The term ‘epidemic’ is increasingly used to describe the rising global prevalence of atrial fibrillation (AF). Indeed, numerous studies are currently investigating the impact of such approaches on clinical outcomes and healthcare utilisation. Recent estimates suggest that AF accounts for between 0.9% 2 Before the.

Risk Factors 59

Risk Factors Atrial Fibrillation Kidney Disease Heart Failure 59

HeartRhythm

MARCH 31, 2025

Catheter ablation is a well-established treatment for atrial fibrillation (AF), yet the optimal timing for the procedure to enhance long-term outcomes remains undefined.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes 40

HeartRhythm

MARCH 31, 2025

Sarcopenia, a progressive skeletal muscle disorder, is associated with adverse outcomes in various cardiovascular conditions. However, its impact on clinical outcomes, especially bleeding and stroke outcomes, in patients with atrial fibrillation (AF) remains unclear.

Atrial Fibrillation 40

Atrial Fibrillation Risk Factors Outcomes Stroke 40

HeartRhythm

MARCH 31, 2025

Catheter ablation effectively restores sinus rhythm in patients with atrial fibrillation (AF). While shorter diagnosis-to-ablation times improve outcomes for de novo catheter ablation, the impact of timing on repeat ablations for recurrent AF is unclear. However, recurrence rates after ablation remain significant.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes 40

HeartRhythm

MARCH 31, 2025

Vein of Marshall ethanol infusion (VoMEI) may improve outcomes among patients with persistent atrial fibrillation (AF) undergoing catheter ablation procedures. Prior investigations used heterogeneous ablation strategies, limiting the understanding of VoMEI utility.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes 40

HeartRhythm

MARCH 31, 2025

Atrial fibrillation (AF) ablation achieves a 6080% success rate in maintaining sinus rhythm at 1 year. Redo ablation procedures are often performed to improve rhythm control and alleviate symptoms, but comprehensive data on long-term outcomes and the optimal timing of these repeat interventions remain limited.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Pulmonary 40

HeartRhythm

MARCH 31, 2025

Atrial fibrillation(AF) is the most common sustained arrhythmia in hypertrophic cardiomyopathy(HCM). AF in HCM increased the risk of morbidity and mortality and patients with HCM and AF have worse clinical outcomes than those without AF.

Atrial Fibrillation 40

Atrial Fibrillation Cardiomyopathy Outcomes Arrhythmia 40

Journal of Cardiovascular Electrophysiology

JANUARY 28, 2024

Abstract Introduction Some previous studies have reported that a first-step ethanol infusion into the vein of Marshall (EIVOM) with touch-up radiofrequency (RF) ablation can facilitate mitral isthmus (MI) block and improves the ablation outcomes in persistent atrial fibrillation (PeAF) patients. 0.78, p  = .006).

Atrial Fibrillation 75

Atrial Fibrillation Ablation Bicuspid/Mitral Tachycardia 75

HeartRhythm

MARCH 31, 2025

The decision to perform catheter ablation for atrial fibrillation (AF) is often driven by symptom severity. However, ablation outcomes in asymptomatic patients compared to symptomatic patients remain underexplored.

Atrial Fibrillation 40

Atrial Fibrillation Ablation AFIB Outcomes 40